Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis
RNA-seq (gene expression) · human · 94 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 94 samples: 35 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE305464_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1306023 and SRA study SRP609011. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 87 samples.
How we read this: 35 replicated groups read from 94 sample titles; they account for 87 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9177451 #975_LTI10_d2_r1 #975_LTI10_d2
- GSM9177452 #975_CP_d2_r1
- GSM9177453 #975_N_d2_r1 #975_N_d2
- GSM9177454 #975_N_d2_r2 #975_N_d2
- GSM9177455 #975_N_d2_r3 #975_N_d2
- GSM9177456 #975_LTI10_d2_r2 #975_LTI10_d2
- GSM9177457 #975_UT_d2_r1 #975_UT_d2
- GSM9177458 #975_UT_d2_r2 #975_UT_d2
- GSM9177459 #975_LTI05_d5_r1
- GSM9177460 #975_LTI3_d5_r1 #975_LTI3_d5
- GSM9177461 #975_LTI3_d5_r2 #975_LTI3_d5
- GSM9177462 #975_LTI3_d5_r3 #975_LTI3_d5
- GSM9177463 #975_LTI10_d5_r1 #975_LTI10_d5
- GSM9177464 #975_LTI10_d5_r2 #975_LTI10_d5
- GSM9177465 #975_CP_d5_r1
- GSM9177466 #975_N_d5_r1 #975_N_d5
- GSM9177467 #975_N_d5_r2 #975_N_d5
- GSM9177468 Gi-51_LTI3_d2_r1 Gi-51_LTI3_d2
- GSM9177469 Gi-51_LTI3_d2_r2 Gi-51_LTI3_d2
- GSM9177470 Gi-51_LTI10_d2_r1 Gi-51_LTI10_d2
- GSM9177471 Gi-51_LTI10_d2_r2 Gi-51_LTI10_d2
- GSM9177472 Gi-51_CP_d2_r1 Gi-51_CP_d2
- GSM9177473 Gi-51_CP_d2_r2 Gi-51_CP_d2
- GSM9177474 Gi-51_N_d2_r1 Gi-51_N_d2
- GSM9177475 Gi-51_N_d2_r2 Gi-51_N_d2
- GSM9177476 Gi-51_N_d2_r3 Gi-51_N_d2
- GSM9177477 Gi-51_UT_d2_r1 Gi-51_UT_d2
- GSM9177478 Gi-51_UT_d2_r2 Gi-51_UT_d2
- GSM9177479 Gi-51_UT_d2_r3 Gi-51_UT_d2
- GSM9177480 Gi-51_LTI05_d5_r1 Gi-51_LTI05_d5
- GSM9177481 Gi-51_LTI05_d5_r2 Gi-51_LTI05_d5
- GSM9177482 Gi-51_LTI05_d5_r3 Gi-51_LTI05_d5
- GSM9177483 Gi-51_LTI3_d5_r1 Gi-51_LTI3_d5
- GSM9177484 Gi-51_LTI3_d5_r2 Gi-51_LTI3_d5
- GSM9177485 Gi-51_LTI3_d5_r3 Gi-51_LTI3_d5
- GSM9177486 Gi-51_LTI10_d5_r1 Gi-51_LTI10_d5
- GSM9177487 Gi-51_LTI10_d5_r2 Gi-51_LTI10_d5
- GSM9177488 Gi-51_LTI10_d5_r3 Gi-51_LTI10_d5
- GSM9177489 Gi-51_CP_d5_r1 Gi-51_CP_d5
- GSM9177490 Gi-51_CP_d5_r2 Gi-51_CP_d5
+ 54 more — browse all 94 samples with per-sample file links →
- GSE137441 Mevastatin Promotes Healing by Targeting Caveolin-1 to Restore EGFR Signaling 6 samples shares caveolin-1
- GSE183289 Regulation of adipogenesis via caveolin-1 in adipose derived mesenchymal stem cells 4 samples shares caveolin-1
- GSE255359 High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer 108 samples shares anti-fibrotic
- GSE318308 Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer 75 samples shares proof-of-concept
- GSE271994 Insights into the Cellular and Molecular Mode of Action behind the Anti-Fibrotic Effects of Nerandomilast 42 samples shares anti-fibrotic
- GSE335951 RamDA-seq analysis of CRISPRa-mediated RELA activation for proof-of-concept validation of CATaN 36 samples shares proof-of-concept
- GSE317322 Gene expression analysis of TGFβ1-stimulated fibroblasts to assess anti-fibrotic effects of the bisubstrate-like NNMT inhibitor II559 9 samples shares anti-fibrotic
- GSE302189 A Liquid biopsy-RNAseq Method for Monitoring the Expression of Genes Involved in Drug Disposition: Proof-of-Concept Application to Cholestatic Disease 6 samples shares proof-of-concept
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.